These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 25737448)

  • 1. Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.
    Rouet R; Dudgeon K; Christie M; Langley D; Christ D
    J Biol Chem; 2015 May; 290(19):11905-17. PubMed ID: 25737448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability.
    Davies J; Riechmann L
    Protein Eng; 1996 Jun; 9(6):531-7. PubMed ID: 8862554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of non-aggregating VH binders from synthetic VH phage-display libraries.
    Arbabi-Ghahroudi M; MacKenzie R; Tanha J
    Methods Mol Biol; 2009; 525():187-216, xiii. PubMed ID: 19252860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
    Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
    J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody VH domains as small recognition units.
    Davies J; Riechmann L
    Biotechnology (N Y); 1995 May; 13(5):475-9. PubMed ID: 9634788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.
    Decanniere K; Desmyter A; Lauwereys M; Ghahroudi MA; Muyldermans S; Wyns L
    Structure; 1999 Apr; 7(4):361-70. PubMed ID: 10196124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a phage-display library of single-domain camelid VH H antibodies directed against Chlamydomonas reinhardtii antigens, and characterization of VH Hs binding cell-surface antigens.
    Jiang W; Rosenberg JN; Wauchope AD; Tremblay JM; Shoemaker CB; Weeks DP; Oyler GA
    Plant J; 2013 Nov; 76(4):709-17. PubMed ID: 23980604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-domain antibody library based on a stability-engineered human VH3 scaffold.
    Lee NJ; Jung M; Yang HY; Shim H
    Sci Rep; 2024 Jul; 14(1):17747. PubMed ID: 39085444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains.
    Barthelemy PA; Raab H; Appleton BA; Bond CJ; Wu P; Wiesmann C; Sidhu SS
    J Biol Chem; 2008 Feb; 283(6):3639-3654. PubMed ID: 18045863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.
    Desmyter A; Spinelli S; Payan F; Lauwereys M; Wyns L; Muyldermans S; Cambillau C
    J Biol Chem; 2002 Jun; 277(26):23645-50. PubMed ID: 11960990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme.
    Desmyter A; Transue TR; Ghahroudi MA; Thi MH; Poortmans F; Hamers R; Muyldermans S; Wyns L
    Nat Struct Biol; 1996 Sep; 3(9):803-11. PubMed ID: 8784355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
    Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
    J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.
    Groves MA; Amanuel L; Campbell JI; Rees DG; Sridharan S; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2014; 6(1):236-45. PubMed ID: 24256948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.
    Nilvebrant J; Ereño-Orbea J; Gorelik M; Julian MC; Tessier PM; Julien JP; Sidhu SS
    J Mol Biol; 2021 Oct; 433(21):167241. PubMed ID: 34508727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
    Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
    Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.
    Tiller T; Schuster I; Deppe D; Siegers K; Strohner R; Herrmann T; Berenguer M; Poujol D; Stehle J; Stark Y; Heßling M; Daubert D; Felderer K; Kaden S; Kölln J; Enzelberger M; Urlinger S
    MAbs; 2013; 5(3):445-70. PubMed ID: 23571156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.